Edouard Chatignoux

Edouard Chatignoux

Auto-generated profile, based on publicly available information

Edouard Chatignoux

French National Public Health Agency, Saint Maurice, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2019 in European Journal of Public Health
Verified
Journal Article
Closed access
VOValérie Olié
Valérie Olié
APAnne Pasquereau
Anne Pasquereau
FAFrank A G Assogba
Frank A G Assogba
PAPierre Arwidson
Pierre Arwidson
VNViet Nguyen-Thanh
Viet Nguyen-Thanh
CBChristophe Bonaldi
Christophe Bonaldi
Background: The high prevalence of smoking among French women since the 1970s has been reflected over the past decade by a strong impact on the health of women. This paper describes age and gender differences in France of the impact of smoking on morbidity and mortality trends since the 2000s. Methods: Smoking prevalence trends were based on estimates from national surveys from 1974 to 2017. Lung cancer incidence were estimated from 2002–12 cancer registry data. Morbidity data for chronic obstructive pulmonary disease (COPD) exacerbation and myocardial infarction were assessed through hospital admissions data, 2002–15. For each disease, number of deaths between 2000 and 2014 came from the national database on medical causes of death. The tobacco-attributable mortality (all causes) was obtained using a population-attributable fraction methodology. Results: The incidence of lung cancer and COPD increased by 72% and 100%, respectively, among women between 2002 and 2015. For myocardial infarction before the age of 65, the incidence increased by 50% between 2002 and 2015 in women vs. 16% in men and the highest increase was observed in women of 45–64-year-olds. Mortality from lung cancer and COPD increased by 71% and 3%, respectively, among women. The estimated number of women who died as a result of smoking has more than doubled between 2000 and 2014 (7% vs. 3% of all deaths). Conclusions: The increase in the prevalence of smoking among women has a major impact on the morbidity and mortality of tobacco-related diseases in women and will continue to increase for a number of years.

1 August 2020 in International Journal of Epidemiology
Verified
Journal Article
Open access
ZUZoé Uhry
Zoé Uhry
ECEdouard Chatignoux
Edouard Chatignoux
EDEmmanuelle Dantony
Emmanuelle Dantony
MCMarc Colonna
Marc Colonna
LRLaurent Roche
Laurent Roche
LRlaurent remontet
laurent remontet
Background: Cancer-incidence and mortality-trend analyses require appropriate statistical modelling. In countries without a nationwide cancer registry, an additional issue is estimating national incidence from local-registry data. The objectives of this study were to (i) promote the use of multidimensional penalized splines (MPS) for trend analyses; (ii) estimate the national cancer-incidence trends, using MPS, from only local-registry data; and (iii) propose a validation process of these estimates.Methods: We used an MPS model of age and year for trend analyses in France over 1990–2015 with a projection up to 2018. Validation was performed for 22 cancer sites and relied essentially on comparison with reference estimates that used the incidence/health-care ratio over the period 2011–2015. Alternative estimates that used the incidence/mortality ratio were also used to validate the trends.Results: In the validation assessment, the relative differences of the incidence estimates (2011–2015) with the reference estimates were <5% except for testis cancer in men and < 7% except for larynx cancer in women. Trends could be correctly derived since 1990 despite incomplete histories in some registries. The proposed method was applied to estimate the incidence and mortality trends of female lung cancer and prostate cancer in France.Conclusions: The validation process confirmed the validity of the national French estimates; it may be applied in other countries to help in choosing the most appropriate national estimation method according to country-specific contexts. MPS form a powerful statistical tool for trend analyses; they allow trends to vary smoothly with age and are suitable for modelling simple as well as complex trends thanks to penalization. Detailed trend analyses of lung and prostate cancers illustrated the suitability of MPS and the epidemiological interest of such analyses.

24 May 2011 in Geophysical Research Letters
Verified
Journal Article
Open access
PDF file
MVMyrto Valari
Myrto Valari
LMLucio Martinelli
Lucio Martinelli
ECEdouard Chatignoux
Edouard Chatignoux
JCJames Crooks
James Crooks
VGValerie Garcia
Valerie Garcia
Strong and non-linear timescale effects between air-pollution and mortalityEvidence of acute air-pollution health effects at the general populationWavelet analysis is a powerful tool in health impact assessment studies

10 July 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CJClarisse Joachim
Clarisse Joachim
JVJacqueline Veronique-Baudin
Jacqueline Veronique-Baudin
LDLaure Desroziers
Laure Desroziers
ÉCÉdouard Chatignoux
Édouard Chatignoux
SBSophie Belliardo
Sophie Belliardo
JDJacqueline Deloumeaux
Jacqueline Deloumeaux
Background: For the first time, we present regional-level cancer incidence and world-standardized mortality rates for cancers for Martinique, Guadeloupe and French Guiana. Methods: For Martinique, Guadeloupe and French Guiana, incidence data come from population-based cancer registries, and cover the periods 2007–2014, 2008–2014 and 2010–2014 respectively. Standardized incidence and mortality rates were calculated using the world population. Results: In the 3 regions, all cancers combined represent 3567 new cases per year, of which 39.8% occur in women, and 1517 deaths per year (43.4% in women). Guadeloupe and Martinique present similar world-standardized incidence rates. Among gynaecological cancers, breast cancer, the second most common cancer type in the 3 regions, has an incidence rate 35 to 46% lower than in mainland France. On the other hand, cervical cancer has a higher incidence rate, particularly in French Guiana. For both endometrial cancer and ovarian cancer, no significant differences in incidence rates are found compared to mainland France. Regarding mortality, world-standardized mortality rates are similar between Guadeloupe and Martinique, and higher than in French Guiana. This situation compares favourably with mainland France (all cancers). Among gynaecological cancers, the mortality rate is lower for breast cancer in all regions compared to mainland France, and also lower for ovarian cancer in Martinique and Guadeloupe, but higher (albeit non-significantly) in French Guiana. Conclusion: The ethno-geographic and socio-demographic characteristics in this population of mainly Afro-Caribbean origin could partially explain these disparities. Major disparities exist for certain cancer sites: excess incidence and excess mortality for cervical cancer; lower, but increasing incidence of breast cancer.

29 March 2018 in Biostatistics
Verified
Journal Article
Closed access
ÉCÉdouard Chatignoux
Édouard Chatignoux
LRLaurent Remontet
Laurent Remontet
JIJean Iwaz
Jean Iwaz
MCMarc Colonna
Marc Colonna
ZUZoé Uhry
Zoé Uhry
There is a growing interest in using health care (HC) data to produce epidemiological surveillance indicators such as incidence. Typically, in the field of cancer, incidence is provided by local cancer registries which, in many countries, do not cover the whole territory; using proxy measures from available nationwide HC databases would appear to be a suitable approach to fill this gap. However, in most cases, direct counts from these databases do not provide reliable measures of incidence. To obtain accurate incidence estimations and prediction intervals, these databases need to be calibrated using a registry-based gold standard measure of incidence. This article presents a calibration model for count data developed to predict cancer incidence from HC data in geographical areas without cancer registries. First, the ratio between the proxy measure and incidence is modeled in areas with registries using a Poisson mixed model that allows for heterogeneity between areas (calibration stage). This ratio is then inverted to predict incidence from the proxy measure in areas without registries. Prediction error admits closed-form expression which accounts for heterogeneity in the ratio between areas. A simulation study shows the accuracy of our method in terms of prediction and coverage probability. The method is further applied to predict the incidence of two cancers in France using hospital data as the proxy measure. We hope this approach will encourage sound use of the usually imperfect information extracted from HC data.

29 July 2022 in International Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
VOV. Olié
V. Olié
ECEdouard Chatignoux
Edouard Chatignoux
CBChristophe Bonaldi
Christophe Bonaldi
CGClémence Grave
Clémence Grave
AGAmélie Gabet
Amélie Gabet
JBJacques Blacher
Jacques Blacher
Background: Hypertension (HT) is a major modifiable risk factor for cardiovascular and renal diseases. HT is diagnosed as blood pressure (BP) exceeding a certain threshold. Because of the high within-person variability of BP, the estimation of HT in epidemiological studies based on single visit measurements tends to overestimate HT prevalence. Our study aimed to determine the correction factors to correct the bias in the estimation of HT prevalence in epidemiological studies.Methods: We used data from the National Health and Nutrition Examination Survey study in which BP was measured at three visits. A Bayesian hierarchical model was used to estimate the different components of BP variability (between individuals, between visits or between measures) by age and sex. These components allowed us to calculate the correction factors necessary to correct HT prevalence in epidemiological studies with single BP measurement. The method was then applied to data from the French Esteban study in which three standardized BP measurements were performed at a single clinical examination.Results: The components of BP variability varied with age and sex, with different patterns observed for systolic and diastolic BP. Between-visit and between-individual variations drove BP variability, with between-measure variability being much lower. The uncorrected prevalence of HT in the Esteban study overestimated the burden of HT by 12.6% in the French population, with more than one in five untreated individuals being misclassified. The overestimation was higher in younger adults and women.Conclusion: Taking into account within-person BP variability in epidemiological studies could avoid a substantial overestimation of the burden of HT.